Exciting news in the world of biotech as Granza Bio, a groundbreaking company specializing in developing cancer therapeutics based on the body's immune system, has successfully raised $7,000,000 in funding. This significant amount will be used to further advance their innovative approach in creating "attack particles" that exclusively target cancer cells without causing any harm to healthy cells, thus minimizing potential side effects commonly associated with traditional cancer treatments. The funding will undoubtedly propel Granza Bio's research and development efforts, paving the way for promising advancements in the field of oncology. Stay tuned for more updates on Granza Bio's groundbreaking work in revolutionizing cancer treatment.












